Company Filing History:
1 out of 16 
1 out of 4 Years Active: 2015
Title: Michael Maria Van Den Heuvel: Innovating Cancer Treatment Predictions
Introduction
Michael Maria Van Den Heuvel is an accomplished inventor based in Amsterdam, Netherlands. He has made significant contributions in the field of oncology, particularly regarding treatment responses for non-small cell lung cancer patients. His innovative spirit, coupled with a deep understanding of medical science, has led to the development of a unique method that aids in predicting the effectiveness of targeted pharmacotherapy for cancer patients.
Latest Patents
Michael holds a patent for a groundbreaking invention titled "Method for predicting the response of non-small cell lung cancer patients to targeted pharmacotherapy." This patent encompasses methods for determining or predicting how patients diagnosed with non-small cell lung cancer will respond to specific treatments. The invention particularly emphasizes measuring kinase activity through the study of phosphorylation levels and profiles, along with the effects of pharmacological inhibitions in patient samples.
Career Highlights
Throughout his career, Michael has accumulated invaluable experience by working with distinguished organizations such as Pamgene B.V. and Stichting Het Nederlands Kanker Instituut. His roles in these companies have facilitated significant advancements in cancer research and treatment methodologies, contributing to the improvement of patient outcomes.
Collaborations
Michael has had the opportunity to collaborate with prominent professionals in his field, including Richard de Wijn and Robby Ruijtenbeek. These partnerships have enabled the sharing of knowledge and resources, fostering an environment conducive to innovation and the development of effective cancer treatment solutions.
Conclusion
Michael Maria Van Den Heuvel stands out as a notable inventor whose work is making a difference in cancer treatment predictions. His patented methods not only enhance the understanding of non-small cell lung cancer but also pave the way for personalized pharmacotherapy, significantly impacting patients' lives. His dedication to research and innovation exemplifies the importance of advancements in the medical field.